IFNG and COVID-19: Further studies would instead be needed to define whether a personalized approach to vaccination, based on surrogate measures of cellular (e.g., interferon-gamma release assays) and humoral (e.g., anti-SARS-CoV-2 neutralizing antibodies) immunity, could help optimize COVID-19 vaccines administration even in elderly and/or fragile populations.